MAPT and early-onset autosomal dominant Alzheimer disease: Consistent with this, hyperphosphorylated Tau is commonly observed in the form of solid aggregates in patients with Alzheimer’s disease and frontotemporal dementia (Kalyaanamoorthy et al. 2024).